Adrian J Park

Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats.

Mohammad A Ghatei, S. Bloom, M. Ghatei, 2002, American journal of physiology. Endocrinology and metabolism.

Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.

Mohammad A Ghatei, Fang Wang, G. Frost, 2005, Endocrinology.

Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial.

Karim Meeran, Mohammad A Ghatei, Katie Wynne, 2005, Diabetes.